Johnson & Johnson announced a lead vaccine candidate for COVID-19
On Mar. 30, 2020, Johnson & Johnson announced the selection of a lead COVID-19 vaccine candidate from constructs…
On Mar. 30, 2020, Johnson & Johnson announced the selection of a lead COVID-19 vaccine candidate from constructs…
On Mar. 29, 2020, a study by UNMC/Nebraska Medicine/NSRI researchers provides new evidence of SARS-CoV-2 environmental contamination in…
On Mar. 28, 2020, the U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to…
On Mar. 27, 2020, Abbott announced the U.S. Food and Drug Administration (FDA) had issued Emergency Use Authorization…
On Mar. 27, 2020, Medtronic announced its Medtronic Care Management Services (MCMS) business had launched two new solutions…
On Mar. 27, 2020, University of Oxford researchers working in an unprecedented vaccine development effort to prevent COVID-19…
On Mar. 27, 2020, researchers at the University of Minnesota reported that the COVID-19 pandemic stands a good…
On Mar. 27, 2020, in response to the crisis caused by the COVID-19 virus in California and around…
On Mar. 27, 2020, Emory’s Vaccine and Treatment Evaluation Unit (VTEU) announced participation in a clinical trial testing…
On Mar. 27, 2020, Syneos Health announced the launch of a Ventilator Initiative. This multi-disciplinary initiative is designed…
On Mar. 27, 2020, Luminex announced the U.S. Food and Drug Administration (FDA) had issued an Emergency Use…
On Mar. 27, 2020, Rice University and Canadian global health design firm Metric Technologies announced they have developed…
On Mar. 26, 2020, Dr. Tedros Adhanom Ghebreyesus, Director-General of the World Health Organization (WHO), addressed Heads of…
On Mar. 26, 2020, Amyris announced that it had completed initial testing of a leading vaccine adjuvant. In…
On Mar. 26, 2020, working in partnership with the Commonwealth of Massachusetts, Massachusetts State Public Health Laboratory, and…
On Mar. 26, 2020, Henry Schein announced the availability of an antibody rapid blood test, known as Standard…
On Mar. 26, 2020, iBio announced that immunization studies for its SARS-CoV-2 Virus-Like Particle program (‘IBIO-200’) were proceeding…
On Mar. 26, 2020, the US Food and Drug Administration (FDA) granted expanded emergency use authorisation (EUA) for…
On Mar. 26, 2020, Thermo Fisher Scientific announced it had received the CE mark in the European Union…
On Mar. 26, 2020, Novartis and a consortium of life sciences companies announced an important collaboration to accelerate the…
On Mar. 26, 2020, the University of California, Berkeley, and University of Illinois at Urbana-Champaign were selected a…
On Mar. 25, 2020, NASA’s Jet Propulsion Laboratory (JPL) in Southern California announced that after receiving more than…
On Mar. 25, 2020, the National Library of Medicine (NLM), part of the National Institutes of Health, announced…
On Mar. 25, 2020, employees of Sartorius Stedim Biotech in Aubagne, France are keeping production running to ensure…
On Mar. 25, 2020, University of Oxford researchers announced they had launched the world’s first COVID-19 government response…
On Mar. 25, 2020, Royal Philips announced that Children’s Hospital of Georgia has adopted Philips’ automated early detection…
On Mar. 25, 2020, a mobility and epidemiological study from a global consortium of researchers, led by the…
On Mar. 25, 2020, a consortium of life sciences companies announced an important collaboration to accelerate the development,…
On Mar. 25, 2020, Vir Biotech announced announced that it has identified multiple human monoclonal antibody (mAb) development…
On Mar. 25, 2020, Xencor announced a technology license agreement with Vir Biotech in which Vir will have…